High levels of drug resistance among infants newly diagnosed with HIV in sub-Saharan Africa
Maternal and child health highlights from CROI 2020
Child with HIV maintains viral suppression for three years off treatment
New approaches for paediatric dosing: abacavir in newborns, doubling dolutegravir with rifampicin
One third of adolescents and young adults on ART in Kenya are not virally suppressed
Azithromycin reduces exacerbations of HIV-related chronic lung disease in children and adolescents
High levels of engagement in care by children and young people with HIV in the UK and Ireland
Without frequent viral load monitoring dolutegravir-based regimens not the best choice for African youth on failing ART
